DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24021553 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Volodymyr V Oberemok und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Genetics and Biotechnologies, Institute of Biochemical Technologies, Ecology and Pharmacy, V.I. Vernadsky Crimean Federal Uni…. Hauptthemen laut MEDLINE: COVID-19, Viral Vaccines. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: framework of state assignment V.I. Vernadsky Crimean Federal University for 2021 and the planning period of 2022–2023, Development of oligonucleotide constructs for making selective and highly effective preparations for medicine and agriculture.
Abstract (Originalsprache)
The SARS-CoV-2 pandemic has demonstrated the need to create highly effective antivirals and vaccines against various RNA viruses, including SARS coronaviruses. This paper provides a short review of innovative strategies in the development of antivirals and vaccines against SARS coronaviruses, with a focus on antisense antivirals, oligonucleotide adjuvants in vaccines, and oligonucleotide vaccines. Well-developed viral genomic databases create new opportunities for the development of innovative vaccines and antivirals using a post-genomic platform. The most effective vaccines against SARS coronaviruses are those able to form highly effective memory cells for both humoral and cellular immunity. The most effective antivirals need to efficiently stop viral replication without side effects. Oligonucleotide antivirals and vaccines can resist the rapidly changing genomic sequences of SARS coronaviruses using conserved regions of their genomes to generate a long-term immune response. Oligonucleotides have been used as excellent adjuvants for decades, and increasing data show that oligonucleotides could serve as antisense antivirals and antigens in vaccine formulations, becoming a prospective tool for immune system tuning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Genetics and Biotechnologies, Institute of Biochemical Technologies, Ecology and Pharmacy, V.I. Vernadsky Crimean Federal University, 295007 Simferopol, Crimea.
ORCID-Profile: Volodymyr V Oberemok
Förderung
- framework of state assignment V.I. Vernadsky Crimean Federal University for 2021 and the planning period of 2022–2023
- Development of oligonucleotide constructs for making selective and highly effective preparations for medicine and agriculture
Zitieren
APA
Oberemok, V. V., Andreeva, O. A., & Alieva, E. E. (2023). DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24021553
Vancouver
Oberemok VV, Andreeva OA, Alieva EE. DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24021553
BibTeX
@article{Oberemok2023,
author = {Oberemok, Volodymyr V and Andreeva, Oksana A and Alieva, Edie E},
title = {DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24021553}
}
EUVIMED